The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThor Energy Regulatory News (THR)

Share Price Information for Thor Energy (THR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
THR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

18 Dec 2017 09:35

RNS Number : 6212Z
Thor Mining PLC
18 December 2017
 

Monday, 18 December 2017

 

THOR MINING PLC

 ("Thor" or the "Company")

 

Appendix 3B

 

The Directors of Thor Mining PLC (AIM, ASX: THR) today released the following announcement on the Australian Securities Exchange ("ASX"), as required under the listing rules of the ASX.

 

 

Enquiries:

Mick Billing

+61 (8) 7324 1935

Thor Mining PLC

Executive Chairman

Ray Ridge

+61 (8) 7324 1935

 

Thor Mining PLC

CFO/Company

Secretary

Colin Aaronson/

Daniel Bush/

Richard Tonthat

+44 (0) 207 383 5100

 

Grant Thornton UK LLP

 

Nominated Adviser

Nick Emerson

+44 (0) 1483 413 500

SI Capital Ltd

Broker

Tim Blythe/ Camilla Horsfall

+44 (0) 207 138 3222

Blytheweigh

Financial PR

 

 

Updates on the Company's activities are regularly posted on Thor's website www.thormining.com, which includes a facility to register to receive these updates by email, and on the Company's twitter page @ThorMining.

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

 

 

Name of entity

Thor Mining PLC

 

ABN

121 117 673

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

(a) Ordinary shares / CDIs

(b) Ordinary shares

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

(a) Transfers of nil to AIM listed shares on the AIM Market of the London Stock Exchange, from ASX listed CDI's, during the period 15 December 2017 to 17 December 2017.

(b) Issue of 13,932,458 Ordinary Shares as a result of options (termed warrants in the UK) being exercised.

 

The total number of securities, listed on both AIM and ASX, is now 598,648,289 as at 18 December 2017.

 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

This represents:

(a) Transfers between AIM listed shares on the AIM Market of the London Stock Exchange, and ASX listed CDI's.

(b) Issue of 13,932,458 Ordinary Shares as a result of the exercise of options.

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

(a) Yes.

(b) Yes.

 

 

5

Issue price or consideration

 

(a) N/A

(b) 2,575,199 at an exercise price of £0.009, 5,776,118 at an exercise price of £0.0125 per share, and 5,581,141 at an exercise price of £0.012 per share.

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

(a) N/A

(b) Issue of Shares as a result of options being exercised. Cash consideration received per above.

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

29 November 2017

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

 

 

 

6f

Number of securities issued under an exception in rule 7.2

(a) N/A

(b) 13,932,458 Ordinary Shares as a result of the exercise of options.

 

 

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements.

N/A

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Refer attached Annexure 1

 

 

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

(a) Transfers 15 December 2017 to 17 December 2017

(b) 18 December 2017

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)

129,606,785

 

Ordinary Shares quoted by

ASX ("THR" as CDIs) as at 18 December 2017.

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

 

 

 

 469,041,504

 

 

 

 

 

8,697,704

 

9,157,408

 

41,557,564

 

19,680,000

 

26,737,316

 

13,840,000

 

2,000,000

 

20,000,000

 

51,111,111

 

15,000,000

 

1,500,000

 

Ordinary Shares admitted to the AIM Market of the London Stock Exchange, as at 18 December 2017.

 

Unlisted Options:

0.9 pence unlisted warrants

 expiring 27 July 2018.

1.2 pence unlisted warrants expiring 2 November 2018

1.2 pence unlisted warrants expiring 29 November 2018

1.25 pence unlisted warrants expiring 1 December 2018.

1.25 pence unlisted warrants expiring 7 April 2019.

1.25 pence unlisted warrants expiring 11 April 2019.

1.8 pence unlisted warrants

 expiring 27 June 2019.

1.25 pence unlisted warrants expiring 26 July 2019.

1.8 pence unlisted warrants

 expiring 28 July 2019.

1.8 pence unlisted warrants

 expiring 31 March 2020.

1.8 pence unlisted warrants

 expiring 27 June 2020.

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No Policy

 

Part 2 ‑ Bonus issue or pro rata issue - Not Applicable

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

ü

Securities described in Part 1

 

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

38

Number of securities for which +quotation is sought

 

 

 

39

Class of +securities for which quotation is sought

 

 

 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another security, clearly identify that other security)

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

 

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

 

 

Sign here: .............................. Date: 18 December 2017

(Company Secretary)

 

Print name: Ray Ridge

 

== == == == ==

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

as at 17 December 2016 317,158,340

 

Add the following:

• Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

Placement (27/1/17) 50,000,000

(approved 27 July 2017)

 

Issue - options exercised 1,780,026

(Issued 17/3/17)

 

Issue - options exercised 3,312,477

(Issued 20/3/17)

 

Issue - options exercised 762,365

(Issued 10/4/17)

 

Placement (28/7/17) 51,111,111

(approved 27 July 2017)

 

Placement (03/11/17) 29,473,686

(approved 29 November 2017)

 

Issue - options exercised 10,000,000

(Issued 10/11/17)

 

Issue - options exercised 20,730,855

(Issued 13/11/17)

 

Issue - options exercised 10,773,161

(Issued 15/11/17)

 

Issue - options exercised 20,749,484

(Issued 21/11/17)

 

Issue - options exercised 18,113,051

(Issued 29/11/17)

 

Placement (30/11/17) 41,151,314

(approved 29 November 2017)

 

Issue - options exercised 8,472,381

(Issued 6/12/17)

Issue - options exercised 13,932,458

(Issued 18/12/17)

 

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

0

 

"A"

597,520,709

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

89,628,106

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

Issue for consideration 1,127,580

(Issued 15/12/17)

 

 

 

 

"C"

1,127,580

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

 

89,628,106

Subtract "C"

Note: number must be same as shown in Step 3

 

1,127,580

Total ["A" x 0.15] - "C"

88,500,526

 [Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

 

597,520,709

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

59,752,070

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

"E"

0

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

 

59,752,070

Subtract "E"

Note: number must be same as shown in Step 3

 

0

Total ["A" x 0.10] - "E"

59,752,070

Note: this is the remaining placement capacity under rule 7.1A

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGCBDDBXBBGRI
Date   Source Headline
3rd May 20227:00 amRNSInvestor Presentation
29th Apr 20227:00 amRNSQuarterly Activites Report
29th Apr 20227:00 amRNSQuarterly Activites Report
4th Apr 20227:00 amRNSUS Uranium and Vanadium - Wedding Bell Update
30th Mar 20229:05 amRNSSecond Price Monitoring Extn
30th Mar 20229:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSLithium Field Program Commences, Ragged Range, WA
18th Mar 202212:36 pmRNSInvestor Presentation
15th Mar 202212:16 pmRNSHalf-year Report
22nd Feb 20227:00 amRNSProject Advancement Alford East Project
7th Feb 202212:37 pmRNSIssue of Equity
4th Feb 20224:41 pmRNSSecond Price Monitoring Extn
4th Feb 20224:36 pmRNSPrice Monitoring Extension
4th Feb 20222:06 pmRNSSecond Price Monitoring Extn
4th Feb 20222:01 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSQuarterly Activity Report October to December 2021
27th Jan 202211:06 amRNSSecond Price Monitoring Extn
27th Jan 202211:01 amRNSPrice Monitoring Extension
27th Jan 20227:00 amRNSLithium Targets Identified at Ragged Range
25th Jan 202211:05 amRNSSecond Price Monitoring Extn
25th Jan 202211:00 amRNSPrice Monitoring Extension
25th Jan 20227:00 amRNSGold Exploration Update at Ragged Range
24th Jan 202212:00 pmRNSPilot Mountain Project Sale
17th Dec 20217:52 amRNSIssue of Equity - Exercise of Options
14th Dec 20217:56 amRNSResult of Placing
13th Dec 20217:00 amRNSASX Trading Halt
9th Dec 20217:00 amRNSCommencement of Kapunda Copper Recovery Trials
7th Dec 20217:00 amRNSMolyhil Third Drillhole Intercepts Mineralisation
25th Nov 20219:15 amRNSIssue of Equity
23rd Nov 20217:00 amRNSOver 45m of Mineralisation Intercepted at Molyhil
22nd Nov 20218:45 amRNSDirector/PDMR Shareholding
16th Nov 20217:32 amRNSStage 1 Earn-in Completed at Alford East
11th Nov 202110:02 amRNSHolding(s) in Company
10th Nov 20211:04 pmRNSResult of AGM
10th Nov 202110:00 amRNSAGM Statement
8th Nov 20217:00 amRNSCommencement of Drilling at Molyhil Project
1st Nov 20217:00 amRNSSale Option Exercised for $1.8m at Pilot Mountain
29th Oct 20217:02 amRNSQuarterly Activity Report July to September 2021
25th Oct 20217:00 amRNSAlford East Presentation
18th Oct 20217:00 amRNSHydrogeology Results
12th Oct 20218:29 amRNSNotice of AGM
11th Oct 20217:00 amRNSRC Drilling Program Commences at Ragged Range
7th Oct 20217:00 amRNSNew Gold Assays Define Drill Ready Targets
4th Oct 20217:00 amRNSBoard Change
30th Sep 20211:11 pmRNSResults for the year ended 30 June 2021
30th Sep 20217:40 amRNSInvestor Presentation
17th Sep 20218:24 amRNSInvestor Presentation
17th Sep 20217:00 amRNSKapunda Drilling
15th Sep 20217:14 amRNSExercise of Options
13th Sep 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.